🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Axsome Therapeutics, Inc. (AXSM)
NASDAQ: AXSM · Real-Time Price · USD
134.00
-1.95 (-1.43%)
At close: Nov 18, 2026, 4:00 PM EST
133.76
-0.24 (-0.18%)
Pre-market: Nov 19, 2026, 8:22 AM EST

Axsome Therapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
865.27638.5385.69270.650.04-
Revenue Growth
54.16%65.55%42.53%440.80%--
Cost of Revenue
58.4247.4833.326.074.1-
Gross Profit
806.85591.02352.39244.5445.94-
Selling, General & Admin
765.54570.6411.36323.12159.2566.65
Research & Development
198.31183.28187.0897.9457.9558.06
Amortization of Goodwill & Intangibles
6.386.386.396.384.14-
Operating Expenses
970.23760.25604.83427.44221.34124.71
Operating Income
-163.38-169.24-252.44-182.91-175.4-124.71
Interest Expense
-12.92-15.93-21.58-20.03-9.66-5.7
Interest & Investment Income
7.39.3715.0113.582.32-
EBT Excluding Unusual Items
-169-175.79-259.01-189.36-182.74-130.4
Merger & Restructuring Charges
-----1.1-
Other Unusual Items
12.35-7.91-28.12-48.92-3.3-
Pretax Income
-156.65-183.7-287.13-238.28-187.13-130.4
Income Tax Expense
0.65-0.530.090.96--
Net Income
-157.29-183.17-287.22-239.24-187.13-130.4
Net Income to Common
-157.29-183.17-287.22-239.24-187.13-130.4
Net Income Growth
------
Shares Outstanding (Basic)
525048454138
Shares Outstanding (Diluted)
525048454138
Shares Change
4.67%3.82%5.48%11.73%8.07%1.11%
EPS (Basic)
-3.05-3.68-5.99-5.27-4.60-3.47
EPS (Diluted)
-3.05-3.68-5.99-5.27-4.60-3.47
EPS Growth
------

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-82.61-93.89-128.68-145.66-117.21-108.53
Free Cash Flow Per Share
-1.60-1.89-2.69-3.21-2.88-2.88
Gross Margin
93.25%92.56%91.36%90.37%91.81%-
Operating Margin
-18.88%-26.51%-65.45%-67.59%-350.54%-
Profit Margin
-18.18%-28.69%-74.47%-88.41%-373.99%-
Free Cash Flow Margin
-9.55%-14.70%-33.36%-53.83%-234.25%-
EBITDA
-152.8-160.17-244.48-176.07-171-124.63
EBITDA Margin
-17.66%-25.09%-63.39%-65.07%--
D&A For EBITDA
10.589.067.966.834.40.08
EBIT
-163.38-169.24-252.44-182.91-175.4-124.71
EBIT Margin
-18.88%-26.51%-65.45%-67.59%--
Revenue as Reported
865.27638.5385.69270.650.04-
Advertising Expenses
-167.1101.2100.335.3-
SEC Filings: 10-K · 10-Q